FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2316181844> ?p ?o ?g. }

• W2316181844 endingPage "592" @default.
• W2316181844 startingPage "588" @default.
• W2316181844 abstract "<h3>Hypothesis:</h3> The purpose of this study was to answer the question whether the measurement of the pretreatment tumor markers and cytokine levels would be of clinical use in patients with cervical adenocarcinoma. <h3>Methods:</h3> CA-125, carcinoembryonic antigen (CEA), and squamous cell carcinoma (SCC), as well as interleukin 6 (IL-6), IL-8, vascular endothelial growth factor, IL-1 receptor antagonist, soluble tumor necrosis factor receptor type I (sTNF RI), and sTNF RII, were assessed in the sera of 120 cervical adenocarcinoma patients. <h3>Results:</h3> CA-125 presented a better diagnostic sensitivity than did CEA and SCC, whereas the concentration of most cytokines, except for sTNF RII, revealed higher sensitivity, than did the standard tumor markers. The highest sensitivity was found for sTNF RI. The concentrations of the examined parameters were found to be significantly higher in patients with advanced stage (IIB-IV) as compared with patients with I-IIA stage. [Float1]Serum concentration of IL-6 was the only one that differs significantly, depending on the histological grade. During the 3-year follow-up, 25 patients relapsed, and 73 patients were disease-free. Significantly higher pretreatment serum concentrations of the examined parameters (except for SCC and IL-1 receptor antagonist) were found in patients who developed recurrences. Soluble tumor necrosis factor receptor type I and CA-125 were found to present the highest sensitivity, with areas under the receiver operating characteristic curve of 0.833 and 0.809, respectively. As the result of univariate analysis, CA-125, CEA, sTNF RII, IL-6, sTNF RI, and clinical stage were considered factors of poor prognosis. Multivariate analysis has proven that CA-125 and clinical stage were the only significant independent prognostic factors of the disease-free survival. <h3>Conclusion:</h3> CA-125 is an independent prognostic factor for disease-free survival. Our results have also demonstrated that sTNF RI is probably the most useful marker in cervical adenocarcinoma patients, especially in the early stages of disease." @default.
• W2316181844 created "2016-06-24" @default.
• W2316181844 creator A5014161273 @default.
• W2316181844 creator A5022569857 @default.
• W2316181844 creator A5027296943 @default.
• W2316181844 creator A5033654048 @default.
• W2316181844 creator A5046429023 @default.
• W2316181844 creator A5054936932 @default.
• W2316181844 creator A5059396547 @default.
• W2316181844 creator A5077493754 @default.
• W2316181844 creator A5084954164 @default.
• W2316181844 creator A5088202134 @default.
• W2316181844 date "2010-05-01" @default.
• W2316181844 modified "2023-10-15" @default.
• W2316181844 title "Clinical Significance of Serum CA-125 and Soluble Tumor Necrosis Factor Receptor Type I in Cervical Adenocarcinoma Patients" @default.
• W2316181844 cites W1963669264 @default.
• W2316181844 cites W1991489880 @default.
• W2316181844 cites W1997773287 @default.
• W2316181844 cites W2016802215 @default.
• W2316181844 cites W2023320895 @default.
• W2316181844 cites W2023331375 @default.
• W2316181844 cites W2032784569 @default.
• W2316181844 cites W2034882585 @default.
• W2316181844 cites W2037396048 @default.
• W2316181844 cites W2045169826 @default.
• W2316181844 cites W2049177915 @default.
• W2316181844 cites W2072205049 @default.
• W2316181844 cites W2081472405 @default.
• W2316181844 cites W2083193799 @default.
• W2316181844 cites W2095462135 @default.
• W2316181844 cites W2103912817 @default.
• W2316181844 cites W2137723939 @default.
• W2316181844 cites W2147215310 @default.
• W2316181844 cites W49316204 @default.
• W2316181844 doi "https://doi.org/10.1111/igc.0b013e3181d5c27a" @default.
• W2316181844 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20686378" @default.
• W2316181844 hasPublicationYear "2010" @default.
• W2316181844 type Work @default.
• W2316181844 sameAs 2316181844 @default.
• W2316181844 citedByCount "16" @default.
• W2316181844 countsByYear W23161818442012 @default.
• W2316181844 countsByYear W23161818442013 @default.
• W2316181844 countsByYear W23161818442014 @default.
• W2316181844 countsByYear W23161818442015 @default.
• W2316181844 countsByYear W23161818442016 @default.
• W2316181844 countsByYear W23161818442017 @default.
• W2316181844 countsByYear W23161818442018 @default.
• W2316181844 countsByYear W23161818442019 @default.
• W2316181844 countsByYear W23161818442020 @default.
• W2316181844 countsByYear W23161818442022 @default.
• W2316181844 countsByYear W23161818442023 @default.
• W2316181844 crossrefType "journal-article" @default.
• W2316181844 hasAuthorship W2316181844A5014161273 @default.
• W2316181844 hasAuthorship W2316181844A5022569857 @default.
• W2316181844 hasAuthorship W2316181844A5027296943 @default.
• W2316181844 hasAuthorship W2316181844A5033654048 @default.
• W2316181844 hasAuthorship W2316181844A5046429023 @default.
• W2316181844 hasAuthorship W2316181844A5054936932 @default.
• W2316181844 hasAuthorship W2316181844A5059396547 @default.
• W2316181844 hasAuthorship W2316181844A5077493754 @default.
• W2316181844 hasAuthorship W2316181844A5084954164 @default.
• W2316181844 hasAuthorship W2316181844A5088202134 @default.
• W2316181844 hasConcept C121608353 @default.
• W2316181844 hasConcept C126322002 @default.
• W2316181844 hasConcept C142724271 @default.
• W2316181844 hasConcept C144301174 @default.
• W2316181844 hasConcept C146357865 @default.
• W2316181844 hasConcept C151730666 @default.
• W2316181844 hasConcept C170493617 @default.
• W2316181844 hasConcept C17991360 @default.
• W2316181844 hasConcept C2777387746 @default.
• W2316181844 hasConcept C2778690821 @default.
• W2316181844 hasConcept C2781182431 @default.
• W2316181844 hasConcept C38180746 @default.
• W2316181844 hasConcept C71924100 @default.
• W2316181844 hasConcept C86803240 @default.
• W2316181844 hasConcept C90924648 @default.
• W2316181844 hasConceptScore W2316181844C121608353 @default.
• W2316181844 hasConceptScore W2316181844C126322002 @default.
• W2316181844 hasConceptScore W2316181844C142724271 @default.
• W2316181844 hasConceptScore W2316181844C144301174 @default.
• W2316181844 hasConceptScore W2316181844C146357865 @default.
• W2316181844 hasConceptScore W2316181844C151730666 @default.
• W2316181844 hasConceptScore W2316181844C170493617 @default.
• W2316181844 hasConceptScore W2316181844C17991360 @default.
• W2316181844 hasConceptScore W2316181844C2777387746 @default.
• W2316181844 hasConceptScore W2316181844C2778690821 @default.
• W2316181844 hasConceptScore W2316181844C2781182431 @default.
• W2316181844 hasConceptScore W2316181844C38180746 @default.
• W2316181844 hasConceptScore W2316181844C71924100 @default.
• W2316181844 hasConceptScore W2316181844C86803240 @default.
• W2316181844 hasConceptScore W2316181844C90924648 @default.
• W2316181844 hasIssue "4" @default.
• W2316181844 hasLocation W23161818441 @default.
• W2316181844 hasLocation W23161818442 @default.
• W2316181844 hasOpenAccess W2316181844 @default.
• W2316181844 hasPrimaryLocation W23161818441 @default.
• W2316181844 hasRelatedWork W1988833395 @default.

• next